Cargando…
Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants
BACKGROUND: Natural products are well recognized as sources of drugs in several human ailments. In the present work, we carried out a preliminary screening of six natural compounds, xanthone V(1) (1); 2-acetylfuro-1,4-naphthoquinone (2); physcion (3); bisvismiaquinone (4); vismiaquinone (5); 1,8-dih...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158745/ https://www.ncbi.nlm.nih.gov/pubmed/21886765 http://dx.doi.org/10.1371/journal.pone.0021762 |
_version_ | 1782210388605009920 |
---|---|
author | Kuete, Victor Wabo, Hippolyte K. Eyong, Kenneth O. Feussi, Michel T. Wiench, Benjamin Krusche, Benjamin Tane, Pierre Folefoc, Gabriel N. Efferth, Thomas |
author_facet | Kuete, Victor Wabo, Hippolyte K. Eyong, Kenneth O. Feussi, Michel T. Wiench, Benjamin Krusche, Benjamin Tane, Pierre Folefoc, Gabriel N. Efferth, Thomas |
author_sort | Kuete, Victor |
collection | PubMed |
description | BACKGROUND: Natural products are well recognized as sources of drugs in several human ailments. In the present work, we carried out a preliminary screening of six natural compounds, xanthone V(1) (1); 2-acetylfuro-1,4-naphthoquinone (2); physcion (3); bisvismiaquinone (4); vismiaquinone (5); 1,8-dihydroxy-3-geranyloxy-6-methylanthraquinone (6) against MiaPaCa-2 pancreatic and CCRF-CEM leukemia cells and their multidrug-resistant subline, CEM/ADR5000. Compounds 1 and 2 were then tested in several other cancer cells and their possible mode of action were investigated. METHODOLOGY/FINDINGS: The tested compounds were previously isolated from the Cameroonian medicinal plants Vismia laurentii (1, 3, 4, 5 and 6) and Newbouldia laevis (2). The preliminary cytotoxicity results allowed the selection of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, which were then tested on a panel of cancer cell lines. The study was also extended to the analysis of cell cycle distribution, apoptosis induction, caspase 3/7 activation and the anti-angiogenic properties of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone. IC(50) values around or below 4 µg/ml were obtained on 64.29% and 78.57% of the tested cancer cell lines for xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, respectively. The most sensitive cell lines (IC(50)<1 µg/ml) were breast MCF-7 (to xanthone V(1)), cervix HeLa and Caski (to xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone), leukemia PF-382 and melanoma colo-38 (to 2-acetylfuro-1,4-naphthoquinone). The two compounds showed respectively, 65.8% and 59.6% inhibition of the growth of blood capillaries on the chorioallantoic membrane of quail eggs in the anti-angiogenic assay. Upon treatment with two fold IC(50) and after 72 h, the two compounds induced cell cycle arrest in S-phase, and also significant apoptosis in CCRF-CEM leukemia cells. Caspase 3/7 was activated by xanthone V(1). CONCLUSIONS/SIGNIFICANCE: The overall results of the present study provided evidence for the cytotoxicity of compounds xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, and bring supportive data for future investigations that will lead to their use in cancer therapy. |
format | Online Article Text |
id | pubmed-3158745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-31587452011-08-30 Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants Kuete, Victor Wabo, Hippolyte K. Eyong, Kenneth O. Feussi, Michel T. Wiench, Benjamin Krusche, Benjamin Tane, Pierre Folefoc, Gabriel N. Efferth, Thomas PLoS One Research Article BACKGROUND: Natural products are well recognized as sources of drugs in several human ailments. In the present work, we carried out a preliminary screening of six natural compounds, xanthone V(1) (1); 2-acetylfuro-1,4-naphthoquinone (2); physcion (3); bisvismiaquinone (4); vismiaquinone (5); 1,8-dihydroxy-3-geranyloxy-6-methylanthraquinone (6) against MiaPaCa-2 pancreatic and CCRF-CEM leukemia cells and their multidrug-resistant subline, CEM/ADR5000. Compounds 1 and 2 were then tested in several other cancer cells and their possible mode of action were investigated. METHODOLOGY/FINDINGS: The tested compounds were previously isolated from the Cameroonian medicinal plants Vismia laurentii (1, 3, 4, 5 and 6) and Newbouldia laevis (2). The preliminary cytotoxicity results allowed the selection of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, which were then tested on a panel of cancer cell lines. The study was also extended to the analysis of cell cycle distribution, apoptosis induction, caspase 3/7 activation and the anti-angiogenic properties of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone. IC(50) values around or below 4 µg/ml were obtained on 64.29% and 78.57% of the tested cancer cell lines for xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, respectively. The most sensitive cell lines (IC(50)<1 µg/ml) were breast MCF-7 (to xanthone V(1)), cervix HeLa and Caski (to xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone), leukemia PF-382 and melanoma colo-38 (to 2-acetylfuro-1,4-naphthoquinone). The two compounds showed respectively, 65.8% and 59.6% inhibition of the growth of blood capillaries on the chorioallantoic membrane of quail eggs in the anti-angiogenic assay. Upon treatment with two fold IC(50) and after 72 h, the two compounds induced cell cycle arrest in S-phase, and also significant apoptosis in CCRF-CEM leukemia cells. Caspase 3/7 was activated by xanthone V(1). CONCLUSIONS/SIGNIFICANCE: The overall results of the present study provided evidence for the cytotoxicity of compounds xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, and bring supportive data for future investigations that will lead to their use in cancer therapy. Public Library of Science 2011-08-19 /pmc/articles/PMC3158745/ /pubmed/21886765 http://dx.doi.org/10.1371/journal.pone.0021762 Text en Kuete et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Kuete, Victor Wabo, Hippolyte K. Eyong, Kenneth O. Feussi, Michel T. Wiench, Benjamin Krusche, Benjamin Tane, Pierre Folefoc, Gabriel N. Efferth, Thomas Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants |
title | Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants |
title_full | Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants |
title_fullStr | Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants |
title_full_unstemmed | Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants |
title_short | Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants |
title_sort | anticancer activities of six selected natural compounds of some cameroonian medicinal plants |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158745/ https://www.ncbi.nlm.nih.gov/pubmed/21886765 http://dx.doi.org/10.1371/journal.pone.0021762 |
work_keys_str_mv | AT kuetevictor anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants AT wabohippolytek anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants AT eyongkennetho anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants AT feussimichelt anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants AT wienchbenjamin anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants AT kruschebenjamin anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants AT tanepierre anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants AT folefocgabrieln anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants AT efferththomas anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants |